➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Boehringer Ingelheim
McKinsey
AstraZeneca
Colorcon

Last Updated: August 5, 2020

DrugPatentWatch Database Preview

DIVIGEL Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Divigel patents expire, and what generic alternatives are available?

Divigel is a drug marketed by Vertical Pharms Llc and is included in one NDA.

The generic ingredient in DIVIGEL is estradiol. There are seventy-five drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the estradiol profile page.

US ANDA Litigation and Generic Entry Outlook for Divigel

A generic version of DIVIGEL was approved as estradiol by MAYNE PHARMA on March 14th, 1996.

  Start Trial

Drug patent expirations by year for DIVIGEL
Drug Prices for DIVIGEL

See drug prices for DIVIGEL

Drug Sales Revenue Trends for DIVIGEL

See drug sales revenues for DIVIGEL

Recent Clinical Trials for DIVIGEL

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Hospital, BonnPhase 1
Finnish Medical FoundationN/A
Päivikki and Sakari Sohlberg Foundation, FinlandN/A

See all DIVIGEL clinical trials

Pharmacology for DIVIGEL
Drug ClassEstrogen
Mechanism of ActionEstrogen Receptor Agonists

US Patents and Regulatory Information for DIVIGEL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vertical Pharms Llc DIVIGEL estradiol GEL;TRANSDERMAL 022038-001 Jun 4, 2007 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Mallinckrodt
Express Scripts
AstraZeneca
Johnson and Johnson
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.